less than both of those Drake’s and Lynch’s types, the cost of deleterious mutations is what drives mutation prices down (Drake 1991; Lynch 2010; Sung et al. 2012). thus, below each models, a rise in the typical cost of mutations would lead to a decrease in mutation premiums. to look at this, Drake examined mutation fees of thermophiles and as